The modular sterile filling system reportedly can deliver 500 to 50,000 units per batch specifically tailored for process development.

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

GreenLight Biosciences España, a biotechnology company pioneering RNA-based solutions for agriculture, announced that it has received a €35M loan from the ...

The Company has also secured its first distribution agreement in the Asia-Pacific region for its SportsGel brand with WPIC Marketing and Technologies (“WPIC”), an Asia Pacific-focused marketing and ...

The FEMSA Biotechnology Center at Tecnologico de Monterrey has worked for over 25 years on the development of nutraceutical ...

Unnatural Products, a Santa Cruz-based biotech company founded by UC Santa Cruz alumni Cameron Pye and Joshua Schwochert ...

The Company believes the business model results in significantly less risk, cost and time to develop its assets compared to traditional biotechnology companies. Marvel Biotechnology Inc. has currently ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.